Integrated Wealth Concepts’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Buy
+26,867
New +$986K 0.01% 1181
2024
Q3
– Sell
-8,887
Closed -$205K – 1709
2024
Q2
$205K Sell
8,887
-509
-5% -$11.9K ﹤0.01% 1513
2024
Q1
$226K Sell
9,396
-9,246
-50% -$217K ﹤0.01% 1467
2023
Q4
$429K Sell
18,642
-38,237
-67% -$768K 0.01% 1068
2023
Q3
$1.16M Sell
56,879
-9,770
-15% -$219K 0.02% 633
2023
Q2
$1.56M Buy
66,649
+55,773
+513% +$1.34M 0.03% 541
2023
Q1
$253K Buy
+10,876
New +$272K 0.01% 1137

Other funds holding IDNA

Integrated Wealth Concepts's IDNA Position: Q3 2026 in Review

Integrated Wealth Concepts opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2026: 26,867 shares worth $1.14M. The stake represents 0.01% of the portfolio and ranks #1181 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in IDNA as recently as Q2 2024.

Integrated Wealth Concepts first reported a position in IDNA in Q1 2023 and has held it in 7 quarters since. The position peaked at $1.56M in Q2 2023. 81 funds tracked by Wall St. Rank hold IDNA as of Q3 2026.

  • Integrated Wealth Concepts held 26,867 shares of iShares Genomics Immunology and Healthcare ETF worth $1.14M as of Q3 2026.
  • iShares Genomics Immunology and Healthcare ETF was a new Integrated Wealth Concepts position in Q3 2026.
  • iShares Genomics Immunology and Healthcare ETF made up 0.01% of Integrated Wealth Concepts's portfolio in Q3 2026, its #1181 holding.
  • Integrated Wealth Concepts first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2023 and has held it in 7 quarters since.
  • Integrated Wealth Concepts's iShares Genomics Immunology and Healthcare ETF position peaked at $1.56M in Q2 2023.
  • 81 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2026.

Based on Integrated Wealth Concepts's 13F filing for Q3 2026, filed 17 Nov 2026.